<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with a hemispheric <z:mpath ids='MPATH_124'>infarct</z:mpath> and massive space-occupying <z:hpo ids='HP_0002181'>brain oedema</z:hpo> have a poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Despite intensive conservative treatment, the case fatality rate may be as high as 80%, and most survivors are left severely disabled </plain></SENT>
<SENT sid="2" pm="."><plain>Non-randomised studies suggest that decompressive surgery substantially reduces mortality and improves the functional outcome of survivors </plain></SENT>
<SENT sid="3" pm="."><plain>The 'Hemicraniectomy after <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> with life-threatening <z:hpo ids='HP_0000969'>edema</z:hpo> trial' (HAMLET) is a newly-conceived randomised multi-centre clinical trial that compares the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction </plain></SENT>
</text></document>